Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder

Recruiting now · Not applicable

Conditions studied: Autism Spectrum Disorder

In brief

Non-invasive vagus nerve stimulation for the symptomatic improvements in Autism Spectrum Disorder

Key facts

Study ID

NCT06473623

Run by

Neuropix

People needed

20

Starts

2025-12-01

Expected to finish

2026-02-10

Last updated by the study team

2026-01-08

Who can join

Age: 7 and older, up to 26. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent
• Age: between 7 and 26 years
• Participants and parent/ guardian must have proficiency in English
• Diagnosis of ASD as defined by ADOS-2 or DSM-5 criteria

You may not qualify if…

• Severe psychiatric disorders (e.g. bipolar, major depressive disorder)
• Severe neurological disorders (e.g. stroke, epilepsy)
• Bradyarrhythmia
• History of head trauma (surgery or tumor)
• Active medical implants (cochlear, VNS or pacemakers)
• Cerebral shunts
• Auricular skin disease that compromises placement of electrodes
• Pregnancy

Where it is running

• Hong Kong Science Park — Tai Po, Hong Kong (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.